2016
Severe post-treatment leukopenia associated with the development of encephalopathy following ifosfamide infusion
Kim S, Isola L, Oh W. Severe post-treatment leukopenia associated with the development of encephalopathy following ifosfamide infusion. Anti-Cancer Drugs 2016, 27: 235-238. PMID: 26628483, DOI: 10.1097/cad.0000000000000321.Peer-Reviewed Original ResearchConceptsIfosfamide-induced encephalopathyCases of ifosfamide-induced encephalopathyDevelopment of ifosfamide-induced encephalopathyIfosfamide-based chemotherapyTreatment sessionsAssociated with encephalopathyDevelopment of encephalopathySeparate treatment sessionsPotential risk factorsIfosfamide infusionIfosfamide therapyRetrospective studyAdverse eventsIfosfamideRisk factorsLeukopeniaSignificantly higher degreeEncephalopathyInfusionPotency analysisLiquid formulationPowder formulationInjection
1999
Contingency Management, Self-Control, and Education Support in the Treatment of Childhood Phobic Disorders: A Randomized Clinical Trial
Silverman W, Kurtines W, Ginsburg G, Weems C, Rabian B, Serafini L. Contingency Management, Self-Control, and Education Support in the Treatment of Childhood Phobic Disorders: A Randomized Clinical Trial. Journal Of Consulting And Clinical Psychology 1999, 67: 675-687. PMID: 10535234, DOI: 10.1037/0022-006x.67.5.675.Peer-Reviewed Original ResearchConceptsPhobic disordersSelf-ControlTreatment conditionsContingency managementControl conditionTreatment programES conditionChildrenTreatment sessionsSC conditionParentsSeparate treatment sessionsEducation supportRelative efficacyComparable improvementKnowledge developmentDisordersClinical trialsTherapistsOutcome measuresConjoint MeetingClinical practicePosttreatmentSessionsImplications
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply